PPubMed3d agoUnbiased CRISPR synthetic lethal screening for genetic vulnerabilities in a succinate dehydrogenase-loss model of paraganglioma.Fatimah J. Al Khazal·L James Maher·Michael J. Emch·Cristina Correia·Judith Favier·John R. HawseRead at PubMedTagsAdrenal and Paraganglionic TumorsSurgery